The cowpox virus late mRNAs encoding the The 3' ends of mRNAs are formed in eukaryotic cells either by the posttranscriptional processing of a primary RNA or, less commonly, by the termination of transcription (reviewed in refs. 1 and 2). The 3' ends of the mRNAs of DNA viruses of most types are formed in a similar way, because most viruses employ the transcriptional apparatus of the cell to synthesize viral mRNAs. The poxviruses differ from other DNA viruses in that they replicate in the cytoplasm of the cell, employing numerous viral enzymes, instead of host cell enzymes, to synthesize their RNAs. Poxviral proteins known to be involved in RNA synthesis and processing include a multisubunit RNA polymerase that resembles eukaryotic RNA polymerase II, several transcription factors, a capping-enzyme complex, an RNA methyltransferase, a poly(A) polymerase, and an endoribonuclease (reviewed in ref. 3). This assemblage of viral proteins suggests that the poxvirus may encode all the factors necessary for viral RNA synthesis, including those required for RNA 3' end formation.
The 3' ends of mRNAs are formed in eukaryotic cells either by the posttranscriptional processing of a primary RNA or, less commonly, by the termination of transcription (reviewed in refs. 1 and 2). The 3' ends of the mRNAs of DNA viruses of most types are formed in a similar way, because most viruses employ the transcriptional apparatus of the cell to synthesize viral mRNAs.
The poxviruses differ from other DNA viruses in that they replicate in the cytoplasm of the cell, employing numerous viral enzymes, instead of host cell enzymes, to synthesize their RNAs. Poxviral proteins known to be involved in RNA synthesis and processing include a multisubunit RNA polymerase that resembles eukaryotic RNA polymerase II, several transcription factors, a capping-enzyme complex, an RNA methyltransferase, a poly(A) polymerase, and an endoribonuclease (reviewed in ref. 3 ). This assemblage of viral proteins suggests that the poxvirus may encode all the factors necessary for viral RNA synthesis, including those required for RNA 3' end formation.
The transcription of poxvirus genes is a temporally regulated process. Early genes are transcribed before viral DNA replication, intermediate genes are transcribed after the onset of viral DNA replication, and late genes are transcribed after the expression of the intermediate genes (reviewed in ref. 4) . The processes used to form the 3' ends of viral RNAs are temporally regulated also. The 3' ends of the early RNAs are generated by the termination of transcription, which occurs about 50 nucleotides downstream of the signal sequence 5'-UUUUUNU-3' in the nascent RNA (5, 6) . Interestingly, the process generating the termination of transcription of early genes does not appear to operate after the onset of viral DNA replication (7) (8) (9) . RNA transcripts of most characterized late genes appear to be heterogeneous in length, lacking the defined 3' ends characteristic of the early mRNAs (10, 11) . However, a few late transcription units whose RNAs are homogeneous in length have been identified. These include the cowpox virus gene encoding the most abundant viral protein, the major protein component of the A-type inclusion (ATI) bodies (12, 13) ; the equivalent vaccinia virus gene (14, 15) ; and the telomeric transcription units of vaccinia virus, cowpox virus, and raccoonpox virus (16 (12, 18) .
Construction of Vaccinia Virus A461. An 850-base-pair (bp) BamHI fragment containing the coding region for the bacterial chloramphenicol acetyltransferase (CAT) gene was isolated from plasmid p863 (obtained from E. Linney, Duke University, Durham, NC), which is a derivative of pSV2-cats (19) . This was inserted into the BamHI site in pTF7-5 (20) , generating plasmid p1373, in which the CAT gene was in the same orientation as the phage T7 promoter. A 2080-bp EcoRI fragment containing the region corresponding to the 3' end of the late mRNAs encoding the major ATI protein was obtained from the Kpn I G-fragment of the DNA of cowpox virus (12) . This fragment was inserted at the EcoPJ site in the CAT gene in p1373, generating plasmid p2098, in which the viral thymidine kinase gene, the phage 17 promoter, the CAT gene, and the 3' end of the gene encoding the ATI protein were all in the same orientation. A vaccinia virus recombinant, A461, containing this gene construction ( Fig. 1) was generated by standard procedures (21), using plasmid p2098 as the insertion vector.
Preparation of Whole-Cell Extracts. Whole-cell extracts were prepared (22) The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. DNA of plasmid p2098 after it had been linearized with Nco I. This generated 2.7-kilobase (kb) RNAs containing the interrupted CAT gene. Cleavage of these RNAs was assayed at 300C in 25-1l reaction mixtures containing 40 mM Tris HC1 (pH 7.9); 40 mM KCl; 6 mM NaCl; 7.6 mM MgCl2; 0.08 mM EDTA; 0.8 mM dithiothreitol; 1.2 mM ATP; 0.12 mM GTP, CTP, and UTP; 3 mM creatine phosphate; 1.2 mM spermidine; 6% (vol/vol) glycerol; 8-10 gg of protein (from 2.5 jAd of whole-cell extract); and 1.5 jig of substrate RNA. RNAs were recovered by ethanol precipitation after proteins had been removed by phenol/chloroform extraction. Before RNA analyses, DNA was removed with RNase-free DNase 1. The 32P-labeled RNAs were resolved by electrophoresis in 1.6% agarose gels containing 2.2 M formaldehyde and were visualized by autoradiography of the dried gels. Reovirus single-stranded RNAs used as size standards were synthesized in vitro as described (23) .
RNA Analyses. Nuclease S1 protection analyses were used to characterize the structure of the 5' and 3' ends of cleaved RNAs. Reaction conditions were as described (12) , except that nuclease S1 was used at a concentration of 1000 units/ ml. Primer extension analyses (12, 24) were used to characterize the structures of RNA 5' ends. RESULTS RNA 3' End Formatn Is Not Dependent upon Either the Promoter or the RNA Polymerase. A cis-acting element directing the site-specific formation ofthe 3' end ofthe mRNAs encoding the ATI protein has been identified within the it directed the formation of late RNAs of a defined length that suggested these RNAs were transcribed from the promoter of the L4R gene ( Fig. 1 ). This demonstrated both that the AX element functions in vaccinia virus as well as cowpox virus, and that it functions downstream oflate promoters other than that of the gene encoding the A1T protein. Moreover, when cells were coinfected with vaccinia virus vTF7-3, which synthesizes the T7 RNA polymerase, additional CAT transcripts were formed (Fig. 1) . Allowing for the additional length caused by the polyadenylylation ofthese RNAs, the 3' ends ofthese RNAs corresponded either tothe position ofthe 17 transcriptional terminator or to the position of the AX element. In contrast, in vitro transcription of the identical DNA template with T7 RNA polymerase failed to generate any CAT transcripts with defined 3' ends other than those corresponding to the site of the 17 transcriptional terminator (data not shown). This indicated that theAX element did not act as a transcriptional termination signal for the T7 RNA polymerase. Significantly, these results demonstrated that the AX element could direct RNA 3' end formation efficiently in cells whether the RNA was generated by the multisubunit RNA polymerase ofthe poxvirus or by the single-polypeptide RNA polymerase of phage T7.
The 3' Ends Are Generated by Site-Specific RNA Cleavage. The lack of dependence upon either promoter or RNA polymerase suggested that the site-specific 3' end formation might occur by a posttranscriptional mechanism. To test this hypothesis, in vitro synthesized RNAs containin the AX element were added to extracts of uninfected or virusinfected cells to assay for 3' end formation dependent upon the AX element. The 32P-labeled RNA substrate used in these assays was a 2.7-kb in vitro transcription product of the 17 promoter-CAT gene construct present in plasmid p2098. This in vitro synthesized RNA was equivalent to the 3.0-kb RNA generated by 17 RNA polymerase in the cells (Fig. 1) other about 1.6 kb long (Fig. 2) . Similar conversion was not detected when the RNA 'Was incubated either in buffer alone or in extracts from uninfected cells, suggesting that the conversion required a virus-induced factor. Moreover, the sizes of the fragments generated in the extracts of virusinfected cells suggested that these RNAs were generated by endoribonucleolytic cleavage of the 2.7-kb RNA at a position within the AX element in the RNA. An RNA cleavage at this site would generate the 3' end of a 1.6-kb RNA and the 5' end of a 1.1-kb RNA.
Nuclease Si protection analyses confirmed the generation of RNA 3' ends corresponding to a site within the AX element (Fig. 3) (Fig. 3, lane 6) . However, similar endpoints of complementarity were not detected after the RNA substrate had been incubated in extracts of uninfected Primer extension analysis of the 5' ends of RNA products generated by cleavage in vitro. Unlabeled 2.7-kb RNAs (p2098-derived) were incubated for 5, 20, or 60 min either in extracts of uninfected HeLa cells or in extracts of HeLa cells prepared 15 hr after they had been infected with vaccinia virus. Oligonucleotides (5'-CGGGATCCGTAACGAAACATCCATCG-3'), labeled at their 5' ends with 32p, were annealed to RNAs recovered either from these reaction mixtures (+RNA) or from unsupplemented extracts (-RNA). After DNA synthesis, the cDNA products were resolved by electrophoresis in a 6% polyacrylamide gel containing 8.3 M urea and were visualized by autoradiography. Lane N, products of DNA synthesis using untreated 2.7-kb RNAs as substrate; lanes A, G, C, and T, products of sequence reactions that were coelectrophoresed to provide size markers. The predicted sequence of the cDNA containing the nucleotide (designated + 1) at the first major endpoint of cDNA synthesis is indicated. cells (Fig. 3, lanes 4 ). This result indicated that a factor in the virus-infected cells generated the formation of a novel RNA 3' end whose sequence was 5'-AUUUUAU-3'. The position of this endpoint was consistent both with the predicted site of the 3' end of the 1.6-kb RNAs and with the nucleotide sequence at the 3' end of mRNAs encoding the ATI protein (S. T. Howard, C.A.R., D.D.P., J.B.A., and D.J.P., unpublished data).
The generation of 5' ends corresponding to the sequence downstream of the predicted cleavage site within the AX element was detected by primer extension and nuclease S1 protection analyses. Extension of a primer, which annealed to the RNA substrate about 70 nucleotides downstream ofthe predicted RNA cleavage site, generated two cDNA products that were produced only if the RNA substrate had been incubated in the presence of extract of virus-infected cells (Fig. 4) . The shorter of these two cDNA products was 98 nucleotides long, suggesting that it was derived from an RNA whose 5' end mapped to the predicted site of RNA cleavage. In the RNA substrate, this sequence, 5'-CCGAUAA-3', is immediately downstream of the sequence present at the 3' ends of the 1.6-kb RNAs. The length of the other major cDNA product, about 168 nucleotides, indicated a cDNA 3' end that did not correspond to either the position of any identified RNA 5' ends or the position of any identified RNA 3' ends. This suggested that the longer cDNAs may have been the products of second-strand cDNA synthesis. Consistent with this interpretation, nuclease S1 protection analysis (Fig.  5) identified only a single endpoint of complementarity between the 5' ends ofthe RNA products and a probe extending 1.3 kb upstream of the position of the predicted RNA cleavage site. This single endpoint of complementarity corresponded closely to the position of the sequence 5'-CCGAUAA-3', which the primer extension analysis (Fig. 4) had predicted to be at the 5' end of the RNA.
Primer extension in the presence of dideoxynucleotides generated chain-terminated products corresponding to the Biochemistry: Antczak et al. IG. 5. Nuclease S1 protection analysis of the 5' ends of RNAs generated by cleavage in vitro. Unlabeled 2.7-kb RNAs (p2098-derived) were incubated for 60 min either in extracts of uninfected HeLa cells or in extracts of HeLa cells prepared 15 hr after they had been infected with vaccinia virus. After extraction from the reaction mixtures these RNAs, and also untreated RNAs, untreated 2.7-kb RNAs, and yeast tRNAs, were separately annealed to 32P-labeled probe DNA consisting of a 1455-bp EcoRI-Xba I fragment (5' end-labeled at the Xba I site) containing the sequence corresponding to the position of the RNA 5' end site. Residual single-stranded nucleic acids were digested with nuclease S1. Nuclease-resistant products were resolved by electrophoresis in a 6% polyacrylamide gel containing 8.3 M urea. The 32P-labeled DNA was visualized by autoradiography. Lanes 1-6 contained portions of the DNA probe protected by hybridization to yeast tRNAs (lane 1), untreated 2.7-kb RNAs (lane 2), endogenous RNAs present in the extract of uninfected cells (lane 3), the 2.7-kb RNAs after incubation in the extract of uninfected cells (lane 4), endogenous RNAs present in the extract of virus-infected cells (lane 5), and, the 2.7-kb RNAs after incubation in the extract of virus-infected cells (lane 6). Lanes 7-10 contained the products of sequence reactions using M13mpi8 single-stranded DNA as the template, which were coelectrophoresed to provide size markers. The sequence of the part of the DNA probe containing the nucleotide (designated -1) complementary to that at the 3' end ofthe RNA is indicated. Arrowheads indicate the major endpoints of complementarity between the probe and the cleaved RNAs.
sequence of the partially cleaved RNA template (Fig. 6 ). This confirmed that the primer had annealed at a single position in the substrate RNA. The sequence analysis directly demonstrated that the sequence at the 5' ends ofthe RNAs that were generated by incubation of the RNA substrate in extracts of virus-infected cells was 5'-CCGAUAA-3'. Furthermore, under these reaction conditions, and in the presence of 4 mM sodium pyrophosphate, which inhibits both second-strand cDNA synthesis and the premature termination of reverse transcription (24), significant quantities of the 168-nucleotide cDNAs were not generated.
The identification of novel 3' and 5' RNA ends corresponding to adjacent nucleotides in the substrate RNA within the AX element (Fig. 7) confirmed that a single endonucleolytic event generated the two RNA products. The identification of these cleavage products only after incubation ofthe substrate RNA in the presence of extracts of cells prepared during the late stages of viral replication suggests that the factor responsible for the RNA cleavage is either virus-induced or virusencoded. Site-specific RNA cleavage was not observed in extracts prepared during the early stage of virus replication (unpublished results). When the RNA substrate was incubated in these extracts it was rapidly degraded. FIG. 6 . Nucleotide sequence analysis of the 5' ends of RNAs generated by in vitro cleavage. Conditions for primer extension analysis either of untreated 2.7-kb substrate RNAs or of substrate RNAs that had been incubated in extracts prepared from cells 15 hr after they had been infected with vaccinia virus were as described in Fig. 4 , except that reactions were performed either in the absence of dideoxynucleotides (0), or in the presence of 10 pM dideoxy-ATP, -GTP, -CTP, or -TTP (A, G, C, and T). Primer extensions were also performed in the absence (-PPi) or presence (+PPi) of4 mM sodium pyrophosphate, using the same RNA samples, designated U (untreated RNAs) or V (RNAs incubated in extracts of virus-infected cells). The concentration of each ofthe four dNTPs in these reactions was 500 !&M. Products were resolved by electrophoresis in a 6%o polyacrylamide gel containing 8.3 M urea and were visualized by autoradiography. The cDNA sequence containing the nucleotide (designated +1) at the first major endpoint of cDNA synthesis is indicated. The longer cDNAs are derived from the uncleaved RNA substrate.
DISCUSSION
The results demonstrate that the 3' ends of the late mRNAs encoding the ATI protein are generated by site-specific cleavage of a primary RNA transcript. Cleavage occurs precisely after the sequence 5'-UUUUAU-3' (Fig. 7) , forming a new RNA 3' end, which is then polyadenylylated. This mechanism of RNA 3' end formation is distinct from that employed by the virus during the transcription ofearly genes, when the 3' ends appear to be formed exclusively by the termination of transcription (5) . The latter mechanism of RNA 3' end formation is not operative at late times during viral replication (7) (8) (9) . Therefore, it appears that the poxviruses employ at least two different mechanisms to generate the 3' ends of their RNAs.
It is not known whether the 3' ends of other viral RNAs are generated by site-specific RNA cleavage. With the exception of the telomeric RNAs (16) , all other characterized viral RNAs appear to lack site-specific 3' ends (10, 11) . Although this may indicate that the 3' ends of most viral late RNAs are formed by a different mechanism, the majority of viral late RNAs are <10 kb long (11, 25; unpublished The formation of site-specific 3' ends in the viral mRNAs encoding the ATI protein resembles the process generating the 3' ends of mRNAs in eukaryotic cells insofar as a cis-acting element in the primary transcript directs RNA cleavage, after which the nascent 3' end is polyadenylylated (reviewed in ref. 1). In other respects, there are several differences between the two mechanisms of RNA 3' end formation. (i) The formation of the 3' ends of mammalian mRNAs involves interactions between several trans-acting factors and specific cis-acting elements that include both a polyadenylylation signal, whose consensus sequence is 5'-AAUAAA-3', and a G+U-rich sequence that is downstream of the polyadenylylation site (reviewed in ref.
2). Similar cis-acting elements appear to be lacking in the regions flanking the cleavage site in the viral RNA. (ii) The formation of the 3' ends of most mammalian mRNAs occurs in the nucleus of the cell, whereas the viral RNAs appear to be synthesized exclusively in the cytoplasm. (iii) The limited amount of mRNA 3' end formation that does occur in the cytoplasm, such as that effecting the translational activation of maternal mRNAs during embryogenesis (26, 27) , requires additional factors and the presence of a cytoplasmic polyadenylylation element, whose consensus sequence is 5'-UUUUUAU-3' (28). A similar sequence is present at the cleavage site of the mRNA encoding the ATI protein (Fig. 7) , but the proximity of this sequence to the cleavage site and the lack of other polyadenylylation signal sequences suggest that viral RNAs are neither cleaved nor polyadenylylated by this mechanism. (iv) The virus encodes a poly(A) polymerase that is capable of effecting the 3' polyadenylylation of RNAs in the absence of specific polyadenylylation signals in the RNA substrate (29) (30) (31) (32) . These dissimilarities suggest that the virus and the cell employ different processes to generate the 3' ends of their RNAs.
The nature of the factor effecting the site-specific cleavage of the viral RNAs has yet to be identified. Nonetheless, it is clear that this factor is either induced or activated during the course of viral replication. It is not detectable in extracts of uninfected cells, but it is present both in extracts of HeLa cells infected with vaccinia virus and in extracts of mouse L cells infected with vaccinia virus (unpublished results). It also appears to be present in human 143 cells infected with cowpox virus (12, 14) and in monkey kidney cells infected with vaccinia virus (15) . The viral induction of this RNA cleavage activity in cells ofdifferent types and the propensity of the poxviruses to encode the enzymes that are required for the synthesis and processing of viral RNAs suggest that the factor involved may be encoded by the virus. However, the possibility that the factor is a host cell enzyme which is induced or activated by virus infection has not been ruled out.
Although it is unclear what factor is responsible for the site-specific cleavage of the viral RNAs, the results of this study have shown that this factor, together with the AX element, can be used to generate sequence-specific cleavage in RNAs other than those encoding the ATI protein. This provides a method of directing 3' end formation in RNAs generated in cells infected with poxviruses, without the use of the phage T7 transcriptional apparatus or the inclusion of a self-cleaving ribozyme in the targeted RNA (20, 33) .
Finally, because of the likelihood that viral factors are involved in the cleavage of viral RNAs, and because of the ease with which poxvirus genetic information can be manipulated, the poxviruses should provide a uniquely practical system for studies on endoribonucleolytic mechanisms of RNA 3' end formation.
